Episode
How Digital Health Is Remaking Clinical Trials
- Published
- Jun 10, 2026
- Duration seconds
- 574
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-digital-health-podcast-with-fexingo-wearables-diagnostics-and-health-software-7872006/episodes/how-digital-health-is-remaking-clinical-trials/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-digital-health-podcast-with-fexingo-wearables-diagnostics-and-health-software-7872006/how-digital-health-is-remaking-clinical-trials.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Nearly every major drug company is now weaving digital tools—wearables, smartphones, and connected sensors—directly into how they test new therapies. In this episode, Lucas and Luna look at why decentralized clinical trials have gone from pandemic workaround to permanent fixture, and what that means for both patients and the business of medicine. They walk through the story of Pfizer's Dora trial in advanced breast cancer, where a smartphone app replaced routine in-person visits for symptom tracking, and how that data is now shaping regulatory conversations at the FDA. The hosts also examine the economics: how virtual trial platforms like Medable and Science 37 have raised hundreds of millions in venture funding, and why the contract research organization business—a $60 billion global industry—is racing to retool. If you're building or investing in digital health, this is a shift you can't ignore. #DigitalHealth #ClinicalTrials #DecentralizedTrials #Wearables #Pfizer #Medable #Science37 #FDAClinicalTrials #Pharmaceuticals #CRO #RemoteMonitoring #PatientData #VentureCapital #HealthTech #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #TheDigitalHealthPodcast Keep every episode free: buymeacoffee.com/fexingo